跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,436 条关于
“KT&G”
全部
3,436
临床试验
1,713
药物
758
机构
76
资讯
889
12个月前
Altria Partners with KT&G to Expand Global Nicotine Pouch and Wellness Product Portfolio
12个月前
KT&G Signs Comprehensive MOU with Altria for Nicotine Pouch and Health Functional Foods Collaboration
2年前
Kymera's KT-333 Demonstrates Antitumor Activity in Hematological Cancers in Phase 1 Trial
2年前
Sanofi's KT-474 Shows Promise as First-in-Class MyD88 Inhibitor for Inflammatory Diseases
去年
Sanofi Advances Kymera's Next-Generation IRAK4 Degrader KT-485 to Clinical Testing
去年
Kymera Therapeutics Advances KT-621 into Patient Studies Amid Development Uncertainties
去年
Kymera's STAT3 Degrader KT-333 Shows Promise Across Multiple Lymphomas and Solid Tumors
5个月前
Gilead Exercises Option for Kymera's KT-200 CDK2 Degrader, Triggering $45M Milestone Payment
去年
Kymera Therapeutics Doses First Participant in Phase 1 Trial of Oral STAT6 Degrader KT-621
去年
Kymera's Oral STAT6 Degrader KT-621 Cleared by FDA for Phase 1 Trial
第 1 页,共 89 页
上一页
下一页